Wugen is a Biotech company based in St. Louis, Missouri. It has raised $200M in total funding. Latest round: Series B.
Wugen is a Biotech company based in St. Louis, Missouri. Wugen has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2021. The round record for Wugen runs through 2021; nothing later has been disclosed. Investors on record include Abingworth, Tybourne Capital Management, Fidelity Management & Research Company, Intermediate Capital Group, Sands Capital, Aisling Capital Management and 6 others. 12 distinct backers are named across the disclosed rounds.
Every Wugen figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in St. Louis at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026